NCT06000527 Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ")
| NCT ID | NCT06000527 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Imagine Institute |
| Condition | Juvenile Recurrent Respiratory Papillomatosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-10-01 |
| Primary Completion | 2032-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2022-10-01 with a primary completion date of 2032-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Recurrent respiratory papillomatosis (RRP) is a rare disease. However, it is the most common benign laryngeal tumor in children. To date, no epidemiological data are available in France. The aim of this study is to establish the epidemiology of juvenile PPR.
Eligibility Criteria
Inclusion Criteria: * Patients with juvenile PRR (disease onset before age 18) * Followed in the : * The MALO CRMR * One of the MALO network's CCMRs * One of the main correspondent centers Exclusion Criteria: * Patients objecting to the collection of their personal data * Parents of minor patients objecting to the collection of their child's personal data
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06000527 clinical trial?
This trial is open to participants of all sexes, studying Juvenile Recurrent Respiratory Papillomatosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06000527 currently recruiting?
Yes, NCT06000527 is actively recruiting participants. Contact the research team at nicolas.leboulanger@aphp.fr for enrollment information.
Where is the NCT06000527 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06000527 clinical trial?
NCT06000527 is sponsored by Imagine Institute. The trial plans to enroll 200 participants.